A Study of Extending Relugolix Dosing Intervals Through Addition of Itraconazole or Ritonavir in Prostate Cancer Patients

NCT05679388 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

60

Enrollment

OTHER

Sponsor class

Stopped Terminated by the PI

Conditions

Prostate Cancer
Prostate Cancer Metastatic
Prostate Adenocarcinoma

Interventions

DRUG: Relugolix Pill
DRUG: Ritonavir
DRUG: Itraconazole

Sponsor

University of Chicago